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Vertigo, dizziness, and unsteadiness (VDU) are common symptoms traditionally considered
to result from different kinds of vestibular and non-vestibular dysfunctions. The epidemi-
ology of each symptom and how they relate to each other and to migraine, agoraphobia,
motion sickness susceptibility (MSS), vaso-vagal episodes (VVE), and anxiety-depression
was the object of this population-based study in north-eastern France. A self-administered
questionnaire was returned by 2987 adults (age span 18–86 years, 1471 women). The 1-
year prevalence for vertigo was 48.3%, for unsteadiness 39.1%, and for dizziness 35.6%.
The three symptoms were correlated with each other, occurred mostly (69.4%) in various
combinations rather than in isolation, less than once per month, and 90% of episodes
lasted ≤2 min. The three symptoms were similar in terms of female predominance, tem-
porary profile of the episodes, and their link to falls and nausea. Symptom episodes of
>1 h increase the risk of falls. VDU are much more common than the known prevalence of
vestibular disorders. The number of drugs taken increase VDU even when controlling for
age. Each VDU symptom was correlated with each co-morbidity in Chi-squared tests. The
data suggest that the three symptoms are more likely to represent a spectrum resulting
from a range of similar – rather than from different, unrelated – mechanisms or disorders.
Logistic regressions controlling for each vestibular symptom showed that vertigo correlated
with each co-morbidity but dizziness and unsteadiness did not, suggesting that vertigo is
certainly not a more specific symptom than the other two. A logistic regression using a
composite score of VDU, controlling for each co-morbidity showed a correlation of VDU to
migraine and VVE but not to MSS and not to agoraphobia in men, only in women.
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INTRODUCTION
Vertigo and dizziness rank among the most common reasons
for consultation and referral to specialist care (Sloane, 1989;
Nakashima et al., 1996; Moulin et al., 2003). A methodological
problem affecting studies on vertigo and dizziness is the uneven
use of these terms by the public and professionals (Blakley and
Goebel, 2001).
An approach to the patient based on the quality of four mutually
exclusive symptoms which would predict the underlying cause has
been propagated since the 1970s (Drachman and Hart,1972) and is
still widely taught: (i) vertigo is due to vestibular causes, (ii) presyn-
cope to cardio-vascular causes, (iii) disequilibrium to neurological
causes, and (iv) non-specific dizziness to either psychiatric or
metabolic causes. Recent studies have shown that this approach
is flawed and potentially dangerous, particularly in the emergency
setting (Stanton et al., 2007; Newman-Toker et al., 2008).
The international vestibular community has started to clas-
sify vestibular disorders. A first step was to propose definitions
of symptoms, which are distinctive, non-overlapping and not
mutually exclusive entities, and without any hypothesis regarding
etiology or mechanism (Bisdorff et al., 2009).
The vestibular system works at a subconscious level and serves
many purposes related to oculo-motor control, balance regulation,
and perception of self-motion (Massion and Woollacott, 1996). It
comprises the labyrinthine part of the inner ear and its connections
in the brain stem and cerebellum. However, it also has widespread
cortical connections and the particular feature of being multi-
modal (integrating vestibular, proprioceptive, and visual inputs)
even at the very basic level of the vestibular nuclei (Cullen, 2012).
Dysfunctions can lead to a wide range of symptoms: from basic
perceptual symptoms like vertigo, dizziness, visual and balance
symptoms to problems of emotion, memory, and self-perception
(Borel et al., 2008).
Vertigo and dizziness are also frequently associated with other
common diseases and conditions, such as migraine (Neuhauser
et al., 2001), motion sickness (Dai et al., 2007), faints (Newman-
Toker et al., 2008), and anxiety (Staab and Ruckenstein, 2003;
Eckhardt-Henn et al., 2008).
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This study sets out to examine the prevalence of vertigo, dizzi-
ness, and unsteadiness (VDU) in an adult population. To avoid
the problem of the uneven use of terms, it uses purely phenome-
nological definitions for each. It also makes it possible to establish
the co-occurrence of the three symptoms and whether they relate
differently to markers of severity for balance disorders like falls
and to certain co-morbidities of vestibular disorders.
MATERIALS AND METHODS
In the Centre de Médecine Préventive of Nancy Vandoeuvre (Lor-
raine region, north-eastern France) the nursing staff distributed
and collected questionnaires from 3035 adults≥18 years who had
volunteered to take part in this study. From adolescence through
old age, French people are regularly invited to local centers of
preventive medicine to have a free health check-up. The data were
recorded anonymously and the study followed the rules of the local
ethical committee [comité de protection des personnes (CPP)].
The study used a self-administered questionnaire, which
included some basic demographic data and a medical part. The
questions on VDU were taken from the vestibular part of the Ver-
tigo Symptom Scale (VSS) (Yardley et al., 1992), which describes
to the participant the various symptoms in a way that can easily be
understood, leaves little room for interpretation, and does not use
the technical terms vertigo or dizziness. The descriptions provided
are close to the newly proposed definitions (Bisdorff et al., 2009)
and can therefore be easily transposed into the corresponding
medical term:
• “a feeling that things are spinning or moving around”: vertigo,
• “a feeling of being light-headed, ‘swimmy’ or giddy”: dizziness,
• “feeling unsteady, about to lose balance”: unsteadiness.
For each item participants ticked the duration and frequency
of episodes over the last year. Two items refer to severity: balance-
related falls and “incapacity to stand or walk without support”
(= severe unsteadiness). The developer of the VSS defined two
composite scores:
• vertigo short for VDU symptoms lasting for up to 1 h
(VDUshort),
• vertigo acute for VDU of >1 h plus severe unsteadiness, falls,
and nausea (VDUacute).
For the composite scores a≥4 cut-off was chosen so as to have
a significant level of symptoms.
Further inclusions were the migraine identifier (Lipton et al.,
2003), the Motion Sickness Susceptibility (MSS) Questionnaire
(MSSQ) (Golding, 1998), and vaso-vagal episodes (VVE) (Bosser
et al., 2006). Markers for agoraphobia and anxiety-depression
(AD) were taken from the Marks fear questionnaire (Marks and
Mathews, 1979), using the French translation (Cottraux et al.,
1987). The maximum score was 40 each, with a cut-off of >10.
STATISTICAL METHODOLOGY
To correct for differences between the sample and the general pop-
ulation of Lorraine, weights were defined for gender, age, and level
of education. In each category the weights were the ratio of the
proportion in the general population to the observed proportion
in the sample. All statistical analyses and tests were performed
with weighted data. The statistical package used was SPSS 16.0 for
windows.
Bivariate associations were tested by applying Chi-squared tests.
Multivariate logistic regression was used, with forward stepping, to
explain binary variables from several quantitative and qualitative
covariates. Odds-ratios (OR) estimates were derived from these
logistic models.
RESULTS
Of the 3035 questionnaires returned 2987 (1471 women) were
included, after rejecting those with too many missing or unusable
data. The average age (y) was 45.6 for men and 46.2 for women
with a similar distribution.
GLOBAL PREVALENCE OF VESTIBULAR SYMPTOMS
At least one VDU symptom had occurred at least once in the last
12 months in 59.2% of participants, vertigo (48.3%) was followed
by unsteadiness (39.1%) and dizziness (35.6%). About 90% of each
symptom episodes were of short (≤2 min) duration and occurred
less than once per month (Table 1). The histogram according
to frequency and duration for the three symptoms are similar
(Figure 1 displays the example of vertigo).
Most participants (69.4%) with symptoms experienced more
than one type in various combinations (Table 2). The three symp-
toms were significantly correlated, as were those with short and
long durations.
The risk for falls and severe unsteadiness was significantly
increased if symptoms came in combinations rather than in
isolation, particularly if the combination included unsteadiness.
The risk of nausea was similarly increased for each VDU
symptom – and still further in case of symptom combinations.
Table 1 | One-year prevalence (%) ofVDU symptoms according to
duration and frequency.
Frequency <2min 2–20min 20min–1h Hours >12h
1–3/year Vertigo 25.98* 3.26* 1.52 1.58 1.17
Dizziness 19.44 2.59 1.25 1.29 0.97
Unsteadiness 22.71 2.20 1.35 1.19 1.03
4–12/year Vertigo 14.21* 0.92 0.66 0.61 0.14
Dizziness 10.18 1.32 0.44 0.23 0.22
Unsteadiness 9.89 1.19 0.53 0.4 0.21
>1/month Vertigo 4.42* 0.67 0.31 0.12 0.09
Dizziness 2.41 0.77 0.25 0.14 0.08
Unsteadiness 2.94 0.61 0.29 0.20 0.15
>1/week Vertigo 1.71 0.18 0.10 0.14 0.06
Dizziness 1.03 0.24 0.13 0.11 0.00
Unsteadiness 1.28 0.25 0.10 0.04 0.05
Some participants had short as well as long lasting symptoms, therefore the
sums for each symptom are higher than the global prevalence indicated in the
text. (*Vertigo more prevalent p<0.01).
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Balance-related falls and severe unsteadiness were about three
times more frequent if the symptoms lasted>1 h rather than≤1 h,
and this was true for all three symptoms.
GENDER AND AGE EFFECT
In women the symptoms were more frequent than in men in most
age groups except for≥70 years. The prevalence was similar across
the various age groups except that in women VDUacute was lower
for age group 40–49 years (Table 3).
MEDICATION AND VDU
Leaving aside contraception, 55.4% took no medication and 4.4%
more than six drugs. The number of drugs increased with age.
The prevalence of VDUshort and VDUacute increased signifi-
cantly with the number of drugs, independently of age and gen-
der (Table 4). The risk for VDUshort and VDUacute decreased
with age when controlling for drug intake. Balance-related falls
increased strongly with five or more drugs but were also mildly
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FIGURE 1 |The z-axis represents the prevalence in %, the x -axis the
duration of vertigo-episodes, and the y -axis the frequency of
vertigo-episodes.
increased with exactly one drug. Each VDU symptom was sig-
nificantly correlated to drug intake in Chi-squared tests, but in a
logistic regression controlling age and gender and for each VDU
symptom, unsteadiness was the best explanatory factor.
VDU AND CO-MORBIDITIES
The global prevalence of migraine was 17.90% with the typical
female predominance and decrease over age 50 years, which is
similar to European figures (Stovner and Andree, 2010).
The average agoraphobia score was 4.1 which is comparable
with data from the literature (Mizes and Crawford, 1986). Preva-
lence of moderate or severe MSS in men was 3.9% and in women
11.2%, in a study using the same tool (Bosser et al., 2006) in a
population of students <30 years, the prevalence were 6.0% for
men and 15.7% for women, which is also comparable considering
that MSS tends to decrease with age.
Each VDU symptom was highly correlated with every co-
morbidity in Chi-squared tests (p< 0.001). Table 5 sets out the
results of the logistic regression analysis testing the correlation of
the co-morbidities with each VDU symptom, controlling for age,
gender, and the other VDU symptoms. In this model migraine is
correlated with each VDU symptom, VVE and AD with vertigo
and dizziness, MSS and agoraphobia only with vertigo.
Anxiety-depression and female gender significantly increased
the risk for VDUshort, VDUacute, and all co-morbidities except
AD for VVE. A separate multivariate regression analysis was there-
fore conducted in men and women with and without AD (Table 6).
Migraine increased the risk for VDUshort in men and women
and for VDUacute in women, independently of AD.
Vaso-vagal episodes increased the risk for VDUshort in men
with and without AD, in women without AD, and for VDUacute
in AD women.
In the global analysis the highest OR for MSS were found for
female gender 2.53 (CI 1.92–3.34), followed by AD (OR 2.04; CI
1.51–2.76) and migraine (OR 1.48; CI 1.10–1.98). When con-
trolling for AD and gender, migraine was not significant in men
but still in non-AD women, MSS did not increase the risk for
VDUshort or VDUacute.
In the global analysis the highest risks for agoraphobia were AD
(OR 3.48; CI 2.63–4.61) and female gender OR 2.36 (CI 1.78–3.11).
When the data were controlled for gender and AD, agoraphobia
Table 2 |The prevalence of combinations ofVDU and balance-related fallers, severe unsteadiness, and nausea.
N =1514
% Male
N =1468
% Female
N =2982
%Total
Fallers
(%/Group)
Severe unsteadiness
(%/Group)
Nausea
No sympt 49.6 31.7 40.8 1.2 1.1 20.5
Vert only 9 11.8 10.4 2.0 2.9* 45.3*
Dizz only 3.5 2.6 3.1 0.9 1.1 46.0*
Vert+dizz 5.6 7.6 6.6 3.7 4.7* 51.3*
Unstead only 4.6 4.7 4.6 4.4 5.7* 48.0*
Unstead+ vert 8 9.3 8.6 11.4* 11.9* 52.1*
Unstead+dizz 3.6 2.8 3.2 14.1* 17.3* 65.5*
Vert+dizz+unstead 16.1 29.6 22.7 16.4* 22.3* 68.1*
Vert, vertigo; dizz, dizziness; unstead, unsteadiness. (*p<0.01).
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Table 3 | Percentages per age group and gender comparison forVDUshort,VDUacute, falls, and severe unsteadiness.
Age groups (years) VDUshort VDUacute Fallers Severe
unsteadiness
M/F (%) p M/F (%) p M/F (%) p M/F (%) p
19–29 21/31 <0.01 4/12 <0.01 5/11 <0.05 5/13 <0.02
30–39 12/33 <0.01 4/12 <0.01 6/8 ns 6/10 <0.01
40–49 15/29 <0.01 3/5 ns 4/7 ns 3/11 <0.01
50–59 14/34 <0.01 2/12 <0.01 6/8 ns 6/12 <0.01
60–69 14/21 <0.01 4/8 ns 4/8 <0.01 6/9 ns
≥70 17/17 ns 7/12 ns 3/8 ns 5/7 ns
Table 4 | Number of drugs, age, andVDU.
N Age groups
436 538 587 558 632 220 2971
Number of
drugs
18–29 years
(%)
30–39 years
(%)
40–49 years
(%)
50–59 years
%
60–69 years
%
≥70 years
%
Total
%
VDUshort
% (OR)
VDUacute
% (OR)
Falls
% (OR)
0 85.6 74.3 72.1 46.8 25.8 11.8 55.4 18.5 (1) 4 (1) 5.1 (1)
1 8.9 16.4 14.8 22.0 16.9 11.8 14.7 24.6 (1.58) 9.5 (2.78) 9.8 (2.2)
2 3.4 4.3 5.3 18.1 13.1 26.4 10.3 23.8 (1.85) 6.3 (2.13) 5.3 (1.3) ns
3 1.4 3.3 1.9 8.1 16.5 15.0 7.3 15.9 (1.18) ns 5.6 (2.02) 6.6 (1.7) ns
4 0.2 1.1 1.9 5.7 11.1 8.2 4.6 28.1 (2.72) 7.9 (3.43) 3.6 (1.0) ns
5 0 0.2 2.0 3.0 7.1 9.1 3.2 27.7 (2.74) 15.6 (7.80) 13.2 (4.1)
≥6 0.5 0.4 1.9 3.2 9.5 17.7 4.4 40.2 (4.95) 19.8 (9.35) 12.3 (3.8)
VDUshort
(OR)
1 0.77 ns 0.68 0.65 0.33 0.27
VDUacute
(OR)
1 0.84 ns 0.35 0.45 0.26 0.38
The two columns on the right display the % and OR for VDUshort, VDUacute, and balance-related falls adjusted for age, gender, and number of drugs, taking zero drug
as reference=1.The two lower rows the OR for age groups adjusted for number of drugs, gender and age, taking group 18–29 as reference= 1; ns=not significant.
Table 5 | Logistic regression for each co-morbidity controlling for
gender, age, and eachVDU symptom.
Vertigo Dizziness Unsteadiness
Migraine 1.11 (1.01–1.22) 1.36 (1.21–1.52) 1.14 (1.03–1.26)
MSS 1.18 (1.09–1.26) ns ns
VVE 1.31 (1.20–1.43) 1.18 (1.08–1.29) ns
Agoraphobia 1.32 (1.22–1.41) ns ns
AD 1.22 (1.16–1.34) 1.23 (1.12–1.36) ns
MSS, motion sickness susceptibility; VVE, vaso-vagal episodes; AD, anxiety-
depression. (OR 95% CI).
was found to increase the risk for VDUshort, VDUacute in non-
AD women. In men the only factor was the combination of AD
and MSS.
DISCUSSION
Vertigo, dizziness, and unsteadiness have a high and roughly
even prevalence throughout adult life. The three symptoms are
correlated with each other, usually appear in short episodes
and in various combinations rather than in isolation (Tables 1
and 2), have a similar link to nausea, severe unsteadiness, and
balance-related falls, all have a female predominance (Table 3)
and all are correlated to each co-morbidity evaluated in this
study.
This challenges the traditional view that vertigo is a more
specific symptom resulting from dysfunction of the inner ear
or its immediate connections in the brain stem and cerebellum
(Perrin et al., 2011), whereas dizziness might result from non-
acute vestibular disorders but also from a much wider range of
causes like metabolic, cardio-vascular, or psychiatric disorders
(Baloh, 1996). The present data suggest that the three symp-
toms are more likely to represent a spectrum resulting from
a range of similar – rather than from different, unrelated –
mechanisms or disorders. The lack of specificity of vestibu-
lar symptoms has also been pointed out in clinical studies in
acute vestibular patients (Stanton et al., 2007). This population-
based study seems to be in line with this concept, but cannot
directly support it as the mechanisms in relatively healthy vol-
unteers and seriously ill patients are likely to be of a different
nature.
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Table 6 |VDU and co-morbidities controlled for gender and anxiety-depression.
non AD
AD
VDU short
VDU 
acute
migraine MSS agoraphobia VVE
3.02
(2.21-4.12)
ns
1.97
(1.32-2.94)
1.99
(1.33-2.97)VDU 
short
f
m
2.01
(1.15-3.51)
ns ns ns
ns
2.70
(1.54-4.70)
nsVDU 
acute
            f
m 
2.40
(1.43-4.02)
3.45
(1.66-7.17)
ns Ns
2.59
(1.27-5.27)
2.47
(1.52-4.00)
ns 1.68
(1.15-2.45)
ns ns
migraine
4.75
(2.02-1.16)
ns
            f
m 
Ns ns ns
ns ns ns ns ns
MSS
ns ns ns
            f
m 
Ns ns
ns ns Ns Ns ns
agoraphobia
ns ns Ns
3.05
(1.18-7.88)
            f
m 
ns
4.27
(2.65-6.90)
ns
2.39
(1.34-4.27)
ns
2.39
(1.14-7.57)
VVE
5.18
(2.03-13.20)
ns ns ns ns
            f
m 
The upper part of each cell shows data for non-AD, the lower for AD participants. Data for men under diagonal line and for women above. AD, anxiety-depression; VVE,
vaso-vagal episodes; MSS, motion sickness susceptibility; VDUshort, composite score of VDU symptoms≤1 h; VDUacute, composite score of VDU symptoms>1 h.
Occasional and short lasting and isolated symptoms are very
common in the population of all ages and might not mean any-
thing serious. On the other hand combinations of symptoms and
those lasting for>1 h were correlated with markers of severity like
falls.
Previous epidemiological studies found a similar symptom
prevalence (Hannaford et al., 2005; Neuhauser et al., 2005) but
did not make such a clear distinction between VDU. The study
by Neuhauser et al. (2005) found that vertigo/dizziness was about
six times – and severe symptoms about three times – more preva-
lent than a narrower definition of vertigo resulting from vestibular
disorders. VDUacute, which reflects symptoms of >1 h duration
had a prevalence similar to “vestibular vertigo” as defined in that
study.
This points to a big gap between the prevalence of VDU symp-
toms and that of vestibular diseases. Indeed, the sum of the 1-year
prevalence of the most common vestibular disorders – benign
paroxysmal positional vertigo 1.6% (von Brevern et al., 2007),
vestibular migraine 0.89% (Neuhauser et al., 2006), Menière’s dis-
ease 3.5–513/100000 (Alexander and Harris, 2010), and vestibular
neuritis annual incidence of 3.5/100000 (Strupp and Brandt,
2009) – is well below 5%. It is not clear how this gap is to be
explained, but broadly two, mutually non-exclusive, explanations
should be considered. First, the spectrum of vestibular disorders
might be wider than captured by the present diagnostic criteria. As
the definitions are usually driven by needs of diagnostic certainty,
they tend to give more weight to specificity. The consequence is
that milder forms of disease presentation may not meet the diag-
nostic criteria. The second factor could be thatVDU also arise from
a range non-vestibular conditions, and this explicitly also applies
to vertigo. The study gives some suggestions of which factors might
play a role.
Drugs might be an important factor (Table 4). There is a clear
increase for VDU and falls with the number of drugs taken, and
drug consumption goes up with age. It is not obvious how to
interpret the finding that consumption of exactly one drug also
mildly increased VDU. Each VDU symptom correlated with drug
intake but unsteadiness is the symptom best explained by drugs
in the logistic regression analysis controlling for vertigo, dizzi-
ness, and age. It is well established that drugs increase the risk of
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falls in the elderly (Woolcott et al., 2009), and vertigo/dizziness is
a common side-effect of many drugs like anti-hypertensives and
sedatives.
A surprising finding is that when controlling for drug intake,
VDU decreased with age.
This suggests that drugs or the diseases for which they are pre-
scribed explain a part of VDU, particularly in the elderly and those
elderly people who do not need to take any or only a few drugs
are very healthy and fall less. On the other hand, in young adults
who take little or no medication, the VDU prevalence is similar
to older adults, who usually take many drugs. In young adults,
factors like migraine and VVE seem to be more important for
explaining VDU.
All co-morbidities examined in this study were correlated with
each VDU symptom, which suggests they arise from common
factors, but each symptom might also have a specific compo-
nent. In logistic models controlling for each vestibular symp-
tom, age and gender some differences appeared (Table 5). Ver-
tigo was correlated with each co-morbidity, whereas dizziness
and unsteadiness were not. This would mean that vertigo is
even less, but definitely not more, specific than dizziness or
unsteadiness. VVE was correlated with vertigo and dizziness but
not unsteadiness. There have traditionally been doubts as to
whether orthostatic hypotension could induce spinning vertigo
and in an epidemiological survey on orthostatic hypotension
(Radtke et al., 2011) vertigo was explicitly excluded. However,
recent data have clearly established that a spinning sensation can
be observed in primary cardio-vascular conditions (Newman-
Toker et al., 2008), and our data suggest that VVE could explain
part of the prevalence of dizziness as well as vertigo, particu-
larly among young people and women, where VVE were more
prominent.
In this model agoraphobia was only correlated with vertigo and
AD with vertigo and dizziness. One might have expected from the
data from behavioral and emotional complications of vestibular
disorders that dizziness would come out more prominently here
rather than vertigo (Ruckenstein and Staab, 2009; Staab, 2012).
Migraine was the only co-morbidity correlated to all three VDU
symptoms which suggests that from migraine the whole range of
vestibular symptoms could arise as opposed to the more narrow
definition of vestibular migraine proposed recently (Lempert et al.,
2012).
The co-morbidities examined in this study are known to be
interconnected. Migraine has a link to MSS (Marcus et al., 2005),
VVE to MSS (Bosser et al., 2006), agoraphobia to anxiety (Kessler
et al., 2006), and all to vertigo. Therefore a logistic model was done
to see how they relate when controlling for each other and VDU
before and after and separating genders and AD from non-AD
because VDU and co-morbidities were higher in women and in
AD, except AD in VVE (Table 6).
Migraine has a robust link to VDUshort in men and women
independently of AD and other co-morbidities, in women also
to VDUacute. This finding supports the importance of migraine
for VDU.
Vaso-vagal episode has a link to VDUshort in non-AD-men and
women when controlling for the other co-morbidities and suggest
it to be an important factor for short lasting vestibular symptoms,
particularly in the young and middle aged and is in line with a
recent German study (Radtke et al., 2011).
From the global results the main risk factors for MSS were AD
and female gender. When controlling for these factors MSS was
not linked to VDU and not to migraine in men and only weakly in
women. Since migraine and anxiety are more common in women,
this could explain why studies in migraine patients showed high
rates of MSS (Marcus et al., 2005) but migraine as such might not
be the main factor.
In the global analysis the strongest explanatory factors for ago-
raphobia were AD and female gender. When controlling for gender
and AD, VDU increased the risk of agoraphobia in women but not
in men. In AD-men MSS increased the risk of agoraphobia. The
interface of anxiety and vestibular disease is a complex topic (Bala-
ban et al., 2011), from our data the difference between women and
men is not explained by migraine and that AD is more important
than VDU.
The prevalence of VDU was found to be high across all age
groups but tended to decrease in the age group >70. In other
studies there was usually an increase with age, particularly in stud-
ies focusing on elderly populations of 65–90 year-olds (Jönsson
et al., 2004; Stevens et al., 2008; Gassmann and Rupprecht, 2009).
In a study encompassing the adult population up to 70 years (Han-
naford et al., 2005) there was a mild increase with age in men, but
not in women. The findings in the >70 years in our study are
probably explained by a recruitment bias. To get to the Centre de
Médecine Préventive, persons need to come by their own means.
People who are seriously ill or disabled people or who live in insti-
tutions would normally not come to this kind of health check
because they would be followed up in a different kind of setting.
This selection bias is likely to be more important with increasing
age. The >70 years group was the smallest in our study, and our
weighting correction could probably not control for the selection
bias for healthier elderly adults.
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